Bizarre Patents
An armor with rollers is provided that enables a user to move in all positions by rolling on a hard and smooth surface while constantly varying his bearing points on the ground.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7323315 | Method for reducing effect of hematocrit on measurement of an analyte in whole blood A method for determining the presence and/or amount of an analyte in a sample of whole blood comprises the step of treating the sample with a nonlytic hypertonic salt composition to reduce the hematocrit by reducing the size of the red blood cells. In optical detect... | 01/29/2008 |
| 7139666 | Method for identifying or characterizing properties of polymeric units The invention relates to methods of identifying and characterizing properties of polymers to provide information about the polymer such as the charge of the polymer, the number and types or characteristics of units of the polymer and the sequence of the polymers. Th... | 11/21/2006 |
| 7056504 | Rationally designed heparinases derived from heparinase I and II Modified heparinases having altered binding specificity and activity are provided. Isolated nucleic acids encoding the same as well as vectors and host cells are provided. Methods for using the modified heparinases are also provided. ... | 06/06/2006 |
| 7029906 | Carbonyl stress-ameliorating agents Carbonyl stress-ameliorating agents have been provided, which contain an enzyme having a glyoxalase I activity and a carbonyl compound-reducing agent as the active ingredients. The carbonyl stress-ameliorating agents of the present invention rapidly eliminate carbon... | 04/18/2006 |
| 7026131 | Methods and apparatus for blood typing with optical bio-discs This invention relates to clinical diagnostic assays, related optical bio-discs, and a disc-reading apparatus. The invention is directed to methods and apparatuses for performing immunohematology assays using an optical bio-disc analysis system. The invention is fur... | 04/11/2006 |
| 7005502 | Pharmaceutical preparation comprising vWF propeptide Described is a pharmaceutical preparation for treating blood coagulation disorders comprising an effective amount of vWf propeptide as well as a method for producing such a prepartion. ... | 02/28/2006 |
| 6972041 | Bone xenografts The invention provides an article of manufacture comprising a substantially non-immunogenic bone xenograft for implantation into humans. The invention further provides a method for preparing a bone xenograft by removing at least a portion of a bone from a non-human ... | 12/06/2005 |
| 6969367 | Extracorporeal pathogen reduction system The invention relates to an apparatus system and methods for treatment of virus-infected or pathogen-loaded human blood components separated from normal components comprising a separation apparatus and treatment apparatus system that inactivate pathogens in an extra... | 11/29/2005 |
| 6947849 | Method for identifying or characterizing properties of polymeric units The invention relates to methods of identifying and characterizing properties of polymers to provide information about the polymer such as the charge of the polymer, the number and types or characteristics of units of the polymer and the sequence of the polymers. Th... | 09/20/2005 |
| 6942879 | Bioartificial filtration device for filtering blood to mimic kidney function A novel cell seeded hollow fiber bioreactor is described as a potential bioartificial kidney. Endothelial cells along with pericyte, vascular smooth muscle, and/or mesangial cells or any mesenchymally derived support cells are seeded along a hollow fiber in a perfus... | 09/13/2005 |
| 6767723 | Method for synthesis of nucleic acids An object of the present invention is to provide a method of treatment and a method of storage that are useful in conducting a nucleic acid synthesis procedure capable of directly amplifying an intended nucleic acid in a living body-derived sample without purificati... | 07/27/2004 |
| 6709655 | Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof The present invention is directed to a pharmaceutical composition comprising F(ab′)2 antibody fragments that are preferably free from albumin and of whole antibodies and also substantially free of pyrogens, and an effective amount of a pharmaceutically ... | 03/23/2004 |
| 6576447 | Method for synthesis of nucleic acids An object of the present invention is to provide a novel method for suppressing the action of nucleic acid synthesis inhibitory substances and thereby amplifying a nucleic acid in a sample efficiently. According to the present invention, in a method for synthe... | 06/10/2003 |
| 6475478 | Adsorbent, adsorbing and removing process and adsorber for endogenous cannabinoid There are provided an adsorbent which can effectively adsorb and remove endogenous cannabinoid in fluid, and a process for removing endogenous cannabinoid in fluid by means of the adsorbent. The adsorbent of endogenous cannabinoid is obtained by fixing a ... | 11/05/2002 |
| 6297371 | Process for the preparation of endotoxin-free or endotoxin-depleted nucleic acids and/or oligonucleotides for gene therapy A process for the isolation and purification of nucleic acids and/or oligonucleotides for use in gene therapy wherein said nucleic acids and/or oligonucleotides are isolated or purified from an essentially biological source, characterized in that said ess... | 10/02/2001 |
| 6218101 | Enzymatic method for removal of cryoprotectants from cryopreserved animal cells A method to remove cryoprotectants from cryopreserved biological cells and tissues is described. Enzymes are used to convert compounds used as cryoprotectants for cells during cryopreservation to membrane impermeable products. This process effectively rem... | 04/17/2001 |
| 6187553 | Method of using additive formulation and method for making a tube with an additive formulation An additive formulation comprising heparinase and trehalose, a method for using the formulation and a device containing the formulation. The additive formulation is useful in substantially neutralizing residual heparin from a blood sample when used in a b... | 02/13/2001 |
| 6121428 | Protein recovery The invention herein provides a method for recovering a polypeptide comprising exposing a composition comprising a polypeptide to a reagent which binds to, or modifies, the polypeptide, wherein the reagent is immobilized on a solid phase; and then passing... | 09/19/2000 |
| 6107455 | Removal of protein from natural rubber latex articles A method for lowering the extractable protein content in a natural rubber latex to below 30 parts per million (ppm) comprises the steps of treating by washing a rubber article, such as a rubber glove, with an aqueous solution containing a soluble silicate... | 08/22/2000 |
| 5939259 | Methods and devices for collecting and storing clinical samples for genetic analysis The present invention relates to devices and methods for the collection, storage, and purification of nucleic acids, such as DNA or RNA, from fluid samples for subsequent genetic characterization, primarily by conventional amplification methods. The prese... | 08/17/1999 |
| 5910422 | Stable single liquid alpha-amylase reagent A stable, single liquid alpha-amylase assay reagent comprises a polysaccharide or long chain oligosaccharide substrate for alpha-amylase having an optically detectable label bonded to the reducing end glucose, by a bond cleavable by alpha- or beta-glucosi... | 06/08/1999 |
| 5866317 | Method for collecting hemolymph of insects The present invention herein provides a method for collecting insect hemolymph which permits the collection of hemolymph, at a time, from a vast number of insect bodies, which does not cause any scattering of the hemolymph during collection thereof, which... | 02/02/1999 |
| 5770104 | Detergent compositions containing substantially pure EG III cellulase Disclosed are detergent compositions containing a cleaning effective amount of a surfactant or a mixture of surfactants and from about 0.01 to about 5 weight percent of substantially pure EG III cellulase. Preferably, the detergent composition contains no... | 06/23/1998 |
| 5747663 | Process for the depletion or removal of endotoxins A process is disclosed for reducing or removing endotoxins from compositions containing therapeutic active substances extracted from natural sources by genetic engineering and/or biotechnology. For that purpose, the compositions are treated with chromatog... | 05/05/1998 |
| 5665762 | Decontaminating clinical samples The present invention contemplates methods of decontaminating human fluids prior to processing in the clinical laboratory. The techniques handle large volumes of human serum without impairing the testing results. Novel compounds for photodecontaminating b... | 09/09/1997 |
| 5633130 | Buffer system for increasing seroconversion efficiency A method of increasing efficiency of deantigenation of blood group epitopes on erythrocytes (seroconversion) by exoglycosidases utilizing a step of performing the deantigenation in a zwitterionic buffer. The method provides a buffer system and exoglycosid... | 05/27/1997 |
| 5629198 | Anti-HIV agent The invention relates to an anti-HIV agent comprising, as an active ingredient, at least one porphyrin derivative selected from the following derivatives (A) and (B): (A) porphyrins modified with a compound selected from carbodiimides, alkylenediamines an... | 05/13/1997 |
| 5543115 | Specimen handling device This invention relates to a specimen handling device for collecting, storing, processing and dispensing of samples. The invention provides for the collection of specimens from any solid or semi-solid material, including biological samples, food samples, w... | 08/06/1996 |
| 5501963 | Amplification and detection of nucleic acids in blood samples This invention relates to a process for the amplification of nucleic acids in the form of DNA or RNA from blood samples by means of an enzymatic amplification method, characterized in that no preparation of the blood sample otherwise necessary to prepurif... | 03/26/1996 |
| 5324628 | Use of chymotrypsin for the inactivation of prekallikrein activator In order to avoid the risk of undesired side reactions of blood products, the latter are produced from plasma by using chymotrypsin to inactivate prekallikrein activator. These preparations are obtained by the fractionated enrichment of plasma proteins, w... | 06/28/1994 |
| 5262325 | Method for the enzymatic neutralization of heparin A heparinase formulation derived from Flavobacterium heparinum which meets all requirements for a clinical reagent that can eliminate heparin interference of normal blood function has been developed. The heparinase, derived from Flavobacterium heparinum, ... | 11/16/1993 |
| 5234685 | Method of determining incompatibility-reaction-causing substances in blood products as well as a method of inactivating said incompatibility-reaction-causing substances There is disclosed a method of determining the presence of incompatibility-reaction-causing substances in blood products. There is also disclosed a method of inactivating incompatibility-reaction-causing substances in blood products to be applied therapeu... | 08/10/1993 |
| 5231015 | Methods of extracting nucleic acids and PCR amplification without using a proteolytic enzyme This invention provides a rapid and highly effective method for extracting nucleic acids from cells or virions without the use of proteolytic enzymes. Extraction is accomplished within a few minutes using a lysing composition comprising a buffer, a source... | 07/27/1993 |
| 5149633 | Process and reagent for the specific determination of fructosamine content in blood and samples obtained from blood Process for the specific determination of the serum fructosamine content in blood or in samples obtained from blood by reaction with an appropriate color reagent and measurement of the color change thereby brought about, in which before the color reaction... | 09/22/1992 |
| 5094949 | Use of chymotrypsin for the inactivation of prekallikrein activator In order to avoid the risk of undesired side reactions of blood products, the latter are produced from plasma by using chymotrypsin to inactivate prekallikrein activator. These preparations are obtained by the fractionated enrichment of plasma proteins, w... | 03/10/1992 |
| 5089415 | Method for clotting heparized blood by the addition of protamine, thrombin and snake venom A cocktail reagent preparation for the rapid production of serum contains thrombin, snake venom, and protamine sulfate. The preparation employs very small quantities of clot promoting substances which behave in a synergistic manner such that rapid clottin... | 02/18/1992 |
| 5055388 | Process and reagent composition for determination of fructosamine in body fluids A process for the determination of fructosamine in body fluids by the reaction of a sample solution with a color reagent, wherein the sample liquid is mixed with a buffer solution having a pH value of from 9 to 12, a color-forming reagent and uricase, as ... | 10/08/1991 |
| 4997932 | Method and kit for purifying nucleic acids The invention teaches a method and kit for purifying nucleic acid, such as DNA, from a sample, such as lysed cell or tissue sample. A sample is applied to an anionic exchange matrix column uniformly distributing the sample therein. The column bed is then ... | 03/05/1991 |
| 4945055 | Human chorionic gonadotropin releasing factor A substantially purified human chorionic gonadotropin releasing factor (hCG-RF) which is a glycoprotein with a molecular weight between about 50,000 and about 70,000. This hCG-RF is capable of stimulating release of human chorionic gonadotropin as well as... | 07/31/1990 |
| 4920045 | Detection of occult blood in feces A method for detection of occult blood in a fecal sample which comprises acting a glycosidase type bacteriolytic enzyme on the fecal sample and subjecting the resulting fecal sample to simultaneous detection of hemoglobin, preferably in combination with t... | 04/24/1990 |
